126 related articles for article (PubMed ID: 6123489)
1. Prolactin secretion response to TRH stimulation in acute and chronic schizophrenic patients under neuroleptic treatment.
Cabranes JA; Fuentenebro F; Recio MN; Borque M; Almoguera MI
Int Pharmacopsychiatry; 1982; 17(1):1-7. PubMed ID: 6123489
[TBL] [Abstract][Full Text] [Related]
2. Serum prolactin response to chlorpromazine and psychopathology in schizophrenics: implications for the dopamine hypothesis.
Meltzer HY; Busch D
Psychiatry Res; 1983 Aug; 9(4):285-99. PubMed ID: 6580661
[TBL] [Abstract][Full Text] [Related]
3. Prolactin and TSH responses to TRH and to haloperidol in schizophrenic patients before and after treatment.
Markianos M; Hatzimanolis J; Stefanis C
Eur Neuropsychopharmacol; 1994 Dec; 4(4):513-6. PubMed ID: 7894262
[TBL] [Abstract][Full Text] [Related]
4. Serum neuroleptic and prolactin levels in schizophrenic patients and clinical response.
Meltzer HY; Busch DA; Fang VS
Psychiatry Res; 1983 Aug; 9(4):271-83. PubMed ID: 6580660
[TBL] [Abstract][Full Text] [Related]
5. Effects of six weeks' neuroleptic treatment on the pituitary-thyroid axis in schizophrenic patients.
Martinos A; Rinieris P; Papachristou DN; Souvatzoglou A; Koutras DA; Stefanis C
Neuropsychobiology; 1986; 16(2-3):72-7. PubMed ID: 3108695
[TBL] [Abstract][Full Text] [Related]
6. Lack of tolerance to long-term neuroleptic treatment in dopamine tuberoinfundibular system.
Chouinard G; Annable L; Jones BD; Collu R
Acta Psychiatr Scand; 1981 Nov; 64(5):353-62. PubMed ID: 6126066
[TBL] [Abstract][Full Text] [Related]
7. Dopamine, serotonin and alpha-adrenergic receptor blocking activities in serum and their relationships to prolactin level in schizophrenic patients receiving long-term chlorpromazine treatment.
Nakahara T; Hirano M; Uchimura H; Saito M; Kim JS; Matsumoto T; Yokoo H; Shimomura M; Mukai A
Psychopharmacology (Berl); 1983; 79(2-3):266-70. PubMed ID: 6133307
[TBL] [Abstract][Full Text] [Related]
8. Effect of intramuscular chlorpromazine on serum prolactin levels in schizophrenic patients and normal controls.
Meltzer HY; Busch DA; Creese IR; Snyder SH; Fang VS
Psychiatry Res; 1981 Aug; 5(1):95-105. PubMed ID: 6944710
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine tests during treatment with neuroleptic drugs: I. Plasma prolactin response to chlorpromazine challenge.
Kolakowska T; Fraser S; Franklin M; Knox J
Psychopharmacology (Berl); 1981; 72(3):283-5. PubMed ID: 6111824
[TBL] [Abstract][Full Text] [Related]
10. Prolactin secretion in chronic schizophrenia.
Brambilla F; Guastalla A; Guerrini A; Rovere C; Legnani G; Sarno M; Riggi F
Acta Psychiatr Scand; 1976 Oct; 54(4):275-86. PubMed ID: 826121
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine tests during treatment with neuroleptic drugs. II. The TRH test.
Braddock LE; Blake IM
Br J Psychiatry; 1981 Nov; 139():404-7. PubMed ID: 6120732
[TBL] [Abstract][Full Text] [Related]
12. Prolactin and TSH responses to TRH, chlorpromazine and L-dopa in children with human growth hormone deficiency.
Okada Y; Onishi T; Tanaka K; Morimoto S; Tsuji M; Watanabe K; Okazaki A; Takeuchi T; Kumahara Y
Acta Endocrinol (Copenh); 1978 Jun; 88(2):217-26. PubMed ID: 96645
[TBL] [Abstract][Full Text] [Related]
13. Dissociation of serum prolactin response to sequential thyrotropin-releasing hormone and chlorpromazine stimulation in patients with primary empty sella syndrome.
Futterweit W; Smith H; Holt JE
Fertil Steril; 1984 Oct; 42(4):573-8. PubMed ID: 6436062
[TBL] [Abstract][Full Text] [Related]
14. Serum prolactin levels following intramuscular chlorpromazine: two- and three-hour response as predictors of six-hour response.
Busch DA; Fang VS; Meltzer HY
Psychiatry Res; 1979 Oct; 1(2):153-9. PubMed ID: 45130
[TBL] [Abstract][Full Text] [Related]
15. Prolactin responses to neuroleptics in normal and schizophrenic subjects.
Gruen PH; Sachar EJ; Langer G; Altman N; Leifer M; Frantz A; Halpern FS
Arch Gen Psychiatry; 1978 Jan; 35(1):108-16. PubMed ID: 23087
[TBL] [Abstract][Full Text] [Related]
16. Plasma prolactin levels after TRH and chlorpromazine in normal subjects and patients with impaired pituitary function.
Schwinn G; von zur Mühlen A; Köbberling J; Halves E; Wenzel KW; Meinhold H
Acta Endocrinol (Copenh); 1975 Aug; 79(4):663-76. PubMed ID: 808064
[TBL] [Abstract][Full Text] [Related]
17. Relationships between drug concentrations in serum and CSF, clinical effects and monoaminergic variables in schizophrenic patients treated with sulpiride or chlorpromazine.
Alfredsson G; Bjerkenstedt L; Edman G; Härnryd C; Oxenstierna G; Sedvall G; Wiesel FA
Acta Psychiatr Scand Suppl; 1984; 311():49-74. PubMed ID: 6199949
[TBL] [Abstract][Full Text] [Related]
18. Abnormal growth hormone response to LRH and TRH in adolescent schizophrenic boys.
Gil-Ad I; Dickerman Z; Weizman R; Weizman A; Tyano S; Laron Z
Am J Psychiatry; 1981 Mar; 138(3):357-60. PubMed ID: 6781365
[TBL] [Abstract][Full Text] [Related]
19. Functional evaluation of prolactin secretion in patients with hypothalamic-pituitary disorders.
Tolis G; Goldstein M; Friesen HG
J Clin Invest; 1973 Apr; 52(4):783-8. PubMed ID: 4632690
[TBL] [Abstract][Full Text] [Related]
20. Prolactin and somatotropin responses to TRH in schizophrenic patients.
Posmurová M; Hainer V; Marek J; Filip V; Srámková J
Act Nerv Super (Praha); 1979 Oct; 21(3):171-3. PubMed ID: 117668
[No Abstract] [Full Text] [Related]
[Next] [New Search]
